Should an institution that has commercial rights in a new drug or device be allowed to evaluate the technology?
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 15696219.
- Also identified by PMC identifier 545202.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
In the United States, the passage of the Bayh-Dole Act in 1980 encouraged universities to license inventions for commercial development. Although this financial incentive can stimulate academic researchers to discover new drugs and devices, there is concern that the possibility of monetary reward could distort investigators' objectivity.
Medical subject headings
- Biomedical Research
- Conflict of Interest
- Equipment and Supplies
- Licensure